Get started
Author

Parmeshwar Amatya

Observed names: P N Amatya, Parmeshwar N Amatya, Parmeshwar N. Amatya, Parmeshwar Narayan Amatya
OpenAlex ID: A5083262132
MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining
2018 · Putzer J. Hung, Britney Johnson, et al. · Molecular Cell · 104
PDF
Ribonucleotide reductase small subunit p53R2 suppresses MEK–ERK activity by binding to ERK kinase 2
2009 · C Piao, M Jin, et al. · Oncogene · 30
A role of DNA-dependent protein kinase for the activation of AMP-activated protein kinase in response to glucose deprivation
2012 · Parmeshwar Narayan Amatya, Hong-Beum Kim, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 26
PDF
Inhibition of Marburg Virus RNA Synthesis by a Synthetic Anti-VP35 Antibody
2019 · Parmeshwar Amatya, Nicole Wagner, et al. · ACS Infectious Diseases · 19
The Dual PI3Kδγ Inhibitor Duvelisib Potently Inhibits IL-6 Production and Cytokine Release Syndrome (CRS) While Maintaining CAR-T Function in Vitro and In Vivo
2020 · Parmeshwar N Amatya, Alun J Carter, et al. · Blood · 15
Mechanistic Studies of Cytokine Release Syndrome (CRS) with Roles of Interferon-Gamma (IFN-g) and Tumor Necrosis Factor Alpha (TNF-α) While Maintaining CAR-T Function in Vitro
2023 · Parmeshwar N Amatya, Jingyu Xiang, et al. · Blood · 9
Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models
2023 · Ramzi Abboud, Sena Kim, et al. · Frontiers in Immunology · 7
The Dual PI3Kdg Inhibitor Duvelisib Potently Inhibits Cytokine Release Syndrome (CRS) While Maintaining CAR-T Function
2022 · Parmeshwar N. Amatya, Reyka G. Jayasinghe, et al. · Blood · 3
Identification of Small Molecule Kinase Inhibitors That Potently and Reversibly Block Chimeric Antigen Receptor T Cell Proliferation and Cytotoxicity
2019 · Parmeshwar Amatya, Matthew L. Cooper, et al. · Blood · 2
primary analysis of Phase ib trial of duvelisib for cytokine release syndrome prophylaxis in patients undergoing chimeric antigen receptor T cell therapy for non-hodgkins lymphoma
2025 · Michael Slade, Michael Rettig, et al. · Blood
Mechanism of CRS: Critical Roles of IFN-γ, CD40L, and CD4 Cells.
2025 · Parmeshwar N Amatya, Alun Carter, et al. · Transplantation and Cellular Therapy
9. The dual PI3K inhibitor duvelisib potently inhibits cytokine release syndrome while maintaining CAR-T function
2022 · Parmeshwar Amatya, Alun Carter, et al. · Cancer Genetics
Combined Treatment of Baricitinib and Cyclosporin Prevents Solid Organ Graft Rejection in Mice
2022 · Parmeshwar Amatya, Sena Kim, et al. · Transplantation and Cellular Therapy
Works count: 13
Citation count: 215
H-index: 7
I10-index: 5
Year
Topic
Type